PDEPT: polymer-directed enzyme prodrug therapy
2001
Polymer-Directed Enzyme Prodrug Therapy (PDEPT)
publication
Evidence: moderate
Author Information
Author(s): Satchi R, Connors T A, Duncan R
Primary Institution: Centre for Polymer Therapeutics, The School of Pharmacy, University of London
Hypothesis
Can polymer-directed enzyme prodrug therapy effectively target tumors and enhance drug release?
Conclusion
The study demonstrates that PDEPT can increase drug accumulation in tumors and improve antitumor activity compared to traditional methods.
Supporting Evidence
- PDEPT showed a 4.2-fold increase in tumor accumulation compared to free enzyme.
- The combination of PK1 and PDEPT resulted in 168% antitumor activity compared to 152% for PK1 alone.
- PDEPT demonstrated activity against a COR-L23 xenograft, while PK1 did not.
Takeaway
This study shows a new way to deliver cancer drugs directly to tumors using special polymers, which helps the drugs work better.
Methodology
The study involved administering a polymer-enzyme conjugate to tumor-bearing mice and measuring drug release and tumor accumulation.
Participant Demographics
B16F10 tumor-bearing mice and C57 mice.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website